報價延遲最少15分鐘:2025/11/18 09:14 EST
盤前時段
|
||||
|
1.99 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
--
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.59/-1.29
|
|
企業價值
145.40M
|
| 資產負債 |
|
每股賬面淨值
-0.11
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
4.29M
|
|
每股收益
0.14
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/11/18 09:14 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. |
